TX45 improved both left ventricular function and pulmonary hemodynamics in patients with Group 2 Pulmonary Hypertension in Heart Failure with preserved Ejection Fraction (“PH-HFpEF”), supporting ...

Bisoprolol is clinically feasible option in reducing resting heart rate (RHR) and improving left ventricular ejection ...

Obesity significantly impacts cardiovascular health, increasing risks such as left ventricular hypertrophy, atherosclerosis, ...

Tectonic Therapeutic (TECX) announced positive interim data from the Phase 1b acute hemodynamic clinical trial of its lead product candidate, ...

Tectonic Therapeutic is a biotechnology company focused on the development of novel therapies for cardiovascular diseases, particularly those involving pulmonary hypertension and heart failure. Its ...

The following is a summary of “Cardiopulmonary Ultrasound to Predict Care Escalation in Early Sepsis: A Pilot Study,” ...

Tectonic Therapeutic shares doubled, to $56.80, after the company said it saw positive interim data from a Phase 1b acute hemodynamic clinical trial of its lead product candidate, TX45, a long-acting, ...

The trial's safety results were reassuring, with no serious adverse events or significant changes in vital signs, physical exams, or safety laboratory values post-administration of TX45. Transient ...

Vermont Business Magazine Central Vermont Home Health & Hospice (CVHHH) received a $10,000 grant from the Vermont Mutual Charitable Giving Fund. The grant will help fund CVHHH’s Adult Home Care ...

A 41-year-old man was evaluated for swelling in the ankles and syncope. CT of the chest showed bilateral mediastinal and ...

Alice Hulme was searching Pet Cam footage, trying to make sense of why her French Bulldog died and came across something heartbreaking.

Huntington Medical Research Institutes (HMRI), a pioneer in scientific research with a track record of groundbreaking ...